＜代表論文＞

1. Umekita Y, Kobayashi K, Saheki T, Yoshida H.

　　Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer.

　　Jpn J Cancer Res (現在のCancer Science) 85:825-830, 1994.

2. Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA.

　　Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.

　　Cancer Lett 96:239-243, 1995.

3. Umekita Y, Hiipakka RA, Kokontis JM, Liao S.

　　Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.

　　Proc Natl Acad Sci USA 93:11802-11807, 1996.

4. Umekita Y, Hiipakka RA, Liao S.

　　Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cells.

　　Cancer Lett 113:87-93, 1997.

5. Umekita Y, Sagara Y, Yoshida H.

　　Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast

　　cancer.

　　Jpn J Cancer Res (現在のCancer Science) 89:27-32, 1998.

6. Umekita Y, Ohi Y, Sagara Y, Yoshida H.

　　Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.

　　Int J Cancer 89:484-487, 2000.

7. Umekita Y, Ohi Y, Sagara Y, Yoshida H.

　　Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients.

　　Int J Cancer 98:415-418, 2002.

8. Umekita Y, Ohi Y, Sagara Y, Yoshida H.

　　Clinical significance of occult micrometastases in axillary lymph nodes in "node-negative" breast cancer patients.

　　Jpn J Cancer Res (現在のCancer Science) 93:695-698, 2002.

9. Umekita Y, Ohi Y, Sagara Y, Yoshida H.

　　Expression of maspin predicts poor prognosis in breast-cancer patients.

　　Int J Cancer 100:452-455, 2002.

10. Umekita Y, Yoshida H.

　　Expression of maspin is up-regulated during the progression of mammary ductal carcinoma.

　　Histopathology 42:541-545, 2003.

11. Souda M, Umekita Y,* Abeyama K, Yoshida H. *corresponding author

　　Gene expression profiling during rat mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene.

　　Int J Cancer 125:1285-1297, 2009.

12. Umekita Y, Souda M, Hatanaka K, Hamada T, Yoshioka T, Kawaguchi H, Tanimoto A.

　　Gene expression profile of terminal end buds in rat mammary glands exposed to diethylstilbestrol in neonatal period.

　　Toxicol Letters 205:15-25, 2011.

13. Ohi Y, Umekita Y, Sagara Y, Rai Y, Yotsumoto D, Matsukata A, Baba S, Tamada S, Matsuyama Y, Ando M, Sagara Y, Sasaki M,

　　Tsuchimochi S, Tanimoto A, Sagara Y. Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.

　　Br J Cancer 107:1239-1243, 2012.

14. Takagi Y, Matsuoka Y, Shiomi T, Nosaka K, Takeda C, Haruki T, Araki K, Taniguchi Y, Nakamura H, Umekita Y.* *corresponding author

　　Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring < 3 cm.

　　Histopathology 66:732-739, 2015.

15. Matsuoka Y, Takagi Y, Nosaka K, Sakabe T, Haruki T, Araki K, Taniguchi Y, Shiomi T, Nakamura H, Umekita Y.* *corresponding author

　　Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with lung squamous cell carcinoma.

　　Histopathology 69 (1):114-120, 2016.

16. Kubouchi Y, Yurugi Y, Wakahara M, Sakabe T, Haruki T, Nosaka K, Miwa K, Araki K, Taniguchi Y, Shiomi T, Nakamura H,

　  Umekita Y.* *corresponding author

　　Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung

　　adenocarcinoma.

　　Histopathology 72:490-499, 2018.

17. Umekita Y, Ohi Y, Iwaya O, Souda M, Sagara Y, Tamada S, Yotsumoto D, Tanimoto A.

　　Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.

　　Histopathology 73 (6):916-922, 2018.

18. Kidokoro Y, Sakabe T, Haruki T, Kadonaga T, Nosaka K, Nakamura H, Umekita Y.* *corresponding author

　　Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component.

　　Lung Cancer 147:56-63, 2020.

19. Sakabe T , Wakahara M , Shiota G, Umekita Y.* *corresponding author

　　Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype.

　　Sci Rep 11(1):11321, 2021.